Vivos Therapeutics (VVOS) Return on Capital Employed Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -18,384.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,384.00 |
| Dec 31, 2025 | -16,370.00 |
| Sep 30, 2025 | 3,069.00 |
| Jun 30, 2025 | 7,157.00 |
| Mar 31, 2025 | 37,109.00 |
| Dec 31, 2024 | 42,663.00 |
| Sep 30, 2024 | 27,569.00 |
| Jun 30, 2024 | 11,261.00 |
| Mar 31, 2024 | -18,756.00 |
| Dec 31, 2023 | -26,356.00 |
| Sep 30, 2023 | -32,831.00 |
| Jun 30, 2023 | -24,927.00 |
| Mar 31, 2023 | -28,567.00 |
| Dec 31, 2022 | -25,687.00 |
| Sep 30, 2022 | -1,249.00 |
| Jun 30, 2022 | 1,149.00 |
| Mar 31, 2022 | 4,927.00 |